PTNR yields 129.65% · ABBV yields 3.06%● Live data
📍 PTNR pulled ahead of the other in Year 1
Combined, PTNR + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PTNR + ABBV for your $10,000?
Partner Communications Company Ltd. provides various telecommunication services in Israel. It operates in two segments, Cellular and Fixed-Line. The company offers cellular telephony services, including basic cellular telephony, text messaging, internet browsing and data transfer, content, handset repair, roaming, and services provided to other operators that are permitted to use its cellular network, as well as Machine to Machine and Internet of Things services. It also provides cellular content and value-added services, such as multimedia messaging, cyber protection, cloud backup, ringtone, music streaming, and various business services; and international roaming services, as well as sells and leases cellular handsets, and related cellular devices and accessories. In addition, the company offers Internet service provider (ISP) services comprising email accounts, Wi-Fi networking, anti-virus and anti-spam filtering, and infrastructure and ISP access; network and data infrastructure services, information security and integration solutions, designated services, business information storage services, and data center and cloud services; international long distance services; fixed-line transmission and data capacity services; and voice over broadband telephony and primary rate interface services. Further, it provides television, high speed broadband fiber optic based network, and value added services; and sells and rents modems, domestic routers, servers, and related equipment, as well as tablets, laptops, datacards, audio accessories and other devices, and integration projects. Additionally, the company offers office communication private branch exchange services to business customers. It offers its services and products through sales and service centers, and direct sales force, as well as through dealers and online. The company was incorporated in 1997 and is headquartered in Rosh HaAyin, Israel.
Full PTNR Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.